Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TELA Bio (TELA) Non Operating Income (2018 - 2026)

TELA Bio has reported Non Operating Income over the past 8 years, most recently at $3.9 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 9.48% year-over-year to $3.9 million; the TTM value through Dec 2025 reached $3.7 million, up 160.14%, while the annual FY2025 figure was $1.3 million, 9.37% down from the prior year.
  • Non Operating Income for Q4 2025 was $3.9 million at TELA Bio, up from -$1.0 million in the prior quarter.
  • Over five years, Non Operating Income peaked at $4.7 million in Q4 2022 and troughed at -$3.6 million in Q4 2021.
  • A 5-year average of $193300.0 and a median of -$234500.0 in 2021 define the central range for Non Operating Income.
  • Biggest five-year swings in Non Operating Income: tumbled 4727.27% in 2022 and later skyrocketed 801.31% in 2024.
  • Year by year, Non Operating Income stood at -$3.6 million in 2021, then soared by 230.19% to $4.7 million in 2022, then crashed by 112.91% to -$612000.0 in 2023, then skyrocketed by 801.31% to $4.3 million in 2024, then fell by 9.48% to $3.9 million in 2025.
  • Business Quant data shows Non Operating Income for TELA at $3.9 million in Q4 2025, -$1.0 million in Q3 2025, and $379000.0 in Q2 2025.